MB, Levis & Associates’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
SIMG
AT
EAM
SAM
MB, Levis & Associates's EXEL Position: Q2 2026 in Review
MB, Levis & Associates held its Exelixis (EXEL) position steady in Q2 2026 at 1,000 shares worth $54.4K. The position accounts for 0.02% of the portfolio, ranked #102.
MB, Levis & Associates first reported a position in EXEL in Q4 2022 and has held it in 15 quarters since. The position peaked at $65.5K in Q3 2023. 253 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.
- MB, Levis & Associates held 1,000 shares of Exelixis worth $54.4K as of Q2 2026.
- MB, Levis & Associates left its Exelixis share count unchanged in Q2 2026.
- Exelixis made up 0.02% of MB, Levis & Associates's portfolio in Q2 2026, its #102 holding.
- MB, Levis & Associates first reported a position in Exelixis in Q4 2022 and has held it in 15 quarters since.
- MB, Levis & Associates's Exelixis position peaked at $65.5K in Q3 2023.
- 253 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.
Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.